Colorectal Cancer

Here are the top 5 CURE stories for January 2019.

23andMe received Food and Drug Administration (FDA) clearance for a genetic health risk report on a hereditary colorectal cancer syndrome, according to the genetics company.

When bad things happen to friends we care about, we often stand in silence because we don't know what to say.

Here are the top 5 CURE stories for November 2018.

I would tune out or give an unsympathetic nod when I would hear people talk about anxiety because I didn't understand what it really was or how paralyzing it could be. That was until I got cancer.

An aspirin a day may help keep colorectal cancer at bay, according to recent research.

My son was visibly proud to show me off to his class that day, and I was secretly proud to send his classmates home to talk about poop at the dinner table.

A new American Cancer Society guideline recommends starting screening for colorectal cancer at age 45.

When I was diagnosed with Lynch syndrome seven years ago, I began blogging about the roller coaster of emotions I experienced after undergoing genetic testing and prophylactic surgeries.

A high dose of precision radiation could drastically increase the survival rates of patients with metastatic cancer, and double the time patients live without cancer growth, according to study results presented at the 60th Annual Meeting of the American Society for Radiation Oncology.

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

Immunotherapy pioneers James P. Allison and Dr. Tasuku Honjo have won the 2018 Nobel Prize in Physiology or Medicine for their research that eventually led to the use of immune checkpoint inhibitors to treat cancer.

Getting a third opinion probably didn't save my life, but it definitely bought me more time.

Tumor testing can lead to different treatment choices and better outcomes.

As a parent facing cancer, we just want to know that our children will emerge on the other side of our diagnosis and be alright.

The FDA has granted a breakthrough therapy designation to the combination of the BRAF inhibitor Braftovi (encorafenib), the MEK inhibitor Mektovi (binimetinib), and the EGFR inhibitor Erbitux (cetuximab) for the treatment of patients with BRAF V600E–mutant metastatic colorectal cancer (mCRC) following one or two prior lines of treatment in the metastatic setting.

Scientists have spent 35 years seeking ways to disable RAS, a gene that’s mutated in many cancer types. Now, they’re moving closer to solutions.

The FDA approved Opdivo plus Yervoy to treat a certain subset of patients with metastatic colorectal cancer.

The American Cancer Society issued an updated guideline recommendation that now calls for screening to begin at age 45 for individuals at average risk for colorectal cancer.

Understanding one’s biomarkers, such as microsatellite stable (MSS) or instable (MSI) status in tumors, is key in understanding how a patient with colorectal cancer may be treated.

Take a look at the top five CURE stories of June 2018 in this video.

Recent research found that patients under 50 were less likely to have a treatment-determining biomarker than their older counterparts.

This year’s survey is expanded to better learn about the experience of caregivers, with a selection of questions specifically for them. The Alliance asks that just one caregiver per patient fill out the survey.

Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

The FDA approved the Paxman Scalp Cooling System for patients with solid tumors who wish to prevent chemotherapy-related hair loss.

By getting their tumor genetically tested, a patient may find out that they are eligible for certain treatment options.

It was the drop heard 'round the colorectal cancer world.

After losing her husband and sister to cancer, journalist Katie Couric became an advocate for collaborative efforts to improve prevention and treatment.

The science behind immunotherapy and gastrointestinal cancers is not quite perfected yet, but one subset of patients is seeing remarkable results.